Top Section/Ad
Top Section/Ad
Most recent
Margins widen as lenders weigh up AI disruption to portfolio companies
◆ What strikes on energy infrastructure in the Middle East mean for emerging market bonds ◆ Why issuing in dollars has become so dicey for supranationals and agencies ◆ Europe’s advantage in the private credit meltdown
A slow destruction of misallocated investment is more likely than a sudden stop
Investors confident software fears are overblown
More articles/Ad
More articles/Ad
More articles
-
Andritz, the Austrian machinery maker, raised €400m in a dual tranche Schuldschein transaction this week. The large size — with tenors of seven and 10 years — illustrates commercial banks' growing willingness to lend for long. -
Roughly 40 transactions — if expectations are correct — will close this Schuldschein quarter, exceeding the record 35-37 deals priced in last year’s final quarter. But three Schuldschein bankers believe that if the market becomes even busier investors will be forced to decide between issuers, when, given more time, they would lend to more.
-
German medical firm B. Braun sold what some are calling the tightest six year loan in Schuldschein history this week, even as it more than doubled the €150m initial target. However, some Schuldschein bankers believe German issuers have reached the pricing floor.
-
B. Braun sold the tightest corporate six year loan in Schuldschein history this week. And more, the German medical firm more than doubled the €150m initial target. But, some Schuldschein bankers believe German issuers have reached the market's pricing floor.
-
Amprion, the German electricity transmission firm, launched on Tuesday a €100m Namensschuldverschreibung (NSV) — an instrument with all the qualities of a Schuldschein, except for the issuer’s right to terminate the contract after 10 years.
-
No deterioration in credit quality has taken place among corporate Schuldschein borrowers since 2008, concludes a new report from Helaba, despite the market having undergone huge expansion.
